Conor McNamara
Stock Analyst at RBC Capital
(1.11)
# 3,595
Out of 4,825 analysts
119
Total ratings
30.95%
Success rate
-24.91%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIO Bio-Rad Laboratories | Maintains: Outperform | $409 → $392 | $237.26 | +65.22% | 11 | May 2, 2025 | |
| RGEN Repligen | Maintains: Outperform | $202 → $189 | $140.57 | +34.45% | 11 | Apr 30, 2025 | |
| AVTR Avantor | Maintains: Outperform | $24 → $20 | $12.78 | +56.49% | 7 | Apr 28, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $651 → $637 | $422.79 | +50.67% | 14 | Apr 24, 2025 | |
| DHR Danaher | Reiterates: Outperform | $250 | $199.05 | +25.60% | 9 | Apr 23, 2025 | |
| ILMN Illumina | Maintains: Outperform | $128 → $112 | $77.68 | +44.18% | 15 | Apr 8, 2025 | |
| OABI OmniAb | Maintains: Outperform | $7 → $4 | $1.74 | +129.89% | 3 | Mar 27, 2025 | |
| NTRA Natera | Initiates: Outperform | $251 | $157.19 | +59.68% | 1 | Mar 13, 2025 | |
| QDEL QuidelOrtho | Maintains: Outperform | $64 → $61 | $28.86 | +111.37% | 11 | Feb 13, 2025 | |
| HOLX Hologic | Maintains: Sector Perform | $88 → $85 | $53.70 | +58.29% | 9 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $79 → $80 | $50.49 | +58.45% | 8 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $481 | $234.41 | +105.20% | 10 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $13 | $2.08 | +525.00% | 6 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $3.30 | +112.12% | 4 | Aug 7, 2024 |
Bio-Rad Laboratories
May 2, 2025
Maintains: Outperform
Price Target: $409 → $392
Current: $237.26
Upside: +65.22%
Repligen
Apr 30, 2025
Maintains: Outperform
Price Target: $202 → $189
Current: $140.57
Upside: +34.45%
Avantor
Apr 28, 2025
Maintains: Outperform
Price Target: $24 → $20
Current: $12.78
Upside: +56.49%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $651 → $637
Current: $422.79
Upside: +50.67%
Danaher
Apr 23, 2025
Reiterates: Outperform
Price Target: $250
Current: $199.05
Upside: +25.60%
Illumina
Apr 8, 2025
Maintains: Outperform
Price Target: $128 → $112
Current: $77.68
Upside: +44.18%
OmniAb
Mar 27, 2025
Maintains: Outperform
Price Target: $7 → $4
Current: $1.74
Upside: +129.89%
Natera
Mar 13, 2025
Initiates: Outperform
Price Target: $251
Current: $157.19
Upside: +59.68%
QuidelOrtho
Feb 13, 2025
Maintains: Outperform
Price Target: $64 → $61
Current: $28.86
Upside: +111.37%
Hologic
Feb 6, 2025
Maintains: Sector Perform
Price Target: $88 → $85
Current: $53.70
Upside: +58.29%
Feb 6, 2025
Maintains: Sector Perform
Price Target: $79 → $80
Current: $50.49
Upside: +58.45%
Jan 14, 2025
Reiterates: Outperform
Price Target: $481
Current: $234.41
Upside: +105.20%
Nov 8, 2024
Maintains: Outperform
Price Target: $17 → $13
Current: $2.08
Upside: +525.00%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $3.30
Upside: +112.12%